RTW Biotech Opportunities Ltd RTWFF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 4.38M | 4.38M | 2.39M | 2.39M | 14.89M |
| Total Revenue | 4.38M | 4.38M | 2.39M | 2.39M | 14.89M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 4.38M | 4.38M | 2.39M | 2.39M | 14.89M |
| SG&A Expenses | 3.47M | 3.47M | 3.00M | 3.00M | 3.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.85M | 3.85M | 3.44M | 3.44M | 3.41M |
| Operating Income | 533.20K | 533.20K | -1.04M | -1.04M | 11.48M |
| Income Before Tax | 84.61M | 84.61M | 142.96M | 142.96M | -20.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 84.61M | 84.61M | 142.96M | 142.96M | -20.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.61M | 84.61M | 142.96M | 142.96M | -20.37M |
| EBIT | 533.20K | 533.20K | -1.04M | -1.04M | 11.48M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.26 | 0.26 | 0.44 | 0.44 | -0.06 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.06 | 0.06 | 0.01 |
| EPS Diluted | 0.26 | 0.26 | 0.44 | 0.44 | -0.06 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.06 | 0.06 | 0.01 |
| Average Basic Shares Outstanding | 322.42M | 322.42M | 326.37M | 326.37M | 330.06M |
| Average Diluted Shares Outstanding | 322.42M | 322.42M | 326.37M | 326.37M | 330.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 8.33% | 8.33% | -- | -- | -- |